Our pricing offers a comprehensive approach to weight loss, combining personalized nutrition services and GLP therapy in one affordable monthly plan. Achieve your goals with the support you need, all at a transparent, fixed cost.
Not recommended to combine with other GLP-1 receptor agonists or products containing compounded semaglutide.
The safety and effectiveness of combining with other weight loss products have not been proven.
COMPOUNDED SEMAGLUTIDE and TIRZEPATIDE have not been studied in patients with a history of pancreatitis.
In studies with rodents, semaglutide was shown to cause thyroid C-cell tumors. While it is unclear if this risk applies to humans, patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use COMPOUNDED SEMAGLUTIDE.
Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Counsel patients on the potential risk of MTC and symptoms of thyroid tumors.
Have a personal or family history of MTC or MEN 2.
Have been diagnosed with Type 1 or Type 2 diabetes.
Have a history of pancreatitis or gastroparesis.
Have known allergies to semaglutide or other GLP-1 medications.
Have a history of suicide attempts or active suicidal thoughts.
Acute Pancreatitis: Monitor and discontinue if suspected.
Gallbladder Disease: Evaluate if cholelithiasis is suspected.
Gastroparesis: GLP-1 agonists can cause severe gastrointestinal symptoms.
Hypoglycemia: Risk may increase when used with insulin.
Kidney Injury: Monitor renal function in patients with severe gastrointestinal reactions.
Hypersensitivity: Discontinue if suspected.
Pregnancy: Discontinue immediately if pregnancy is recognized.
Suicidal Behavior and Ideation: Monitor for symptoms of depression or suicidal thoughts.
Pregnancy: May cause fetal harm. Discontinue if pregnancy occurs.
Reproductive Potential: Discontinue at least 2 months prior to planned pregnancy.
Common Side Effects: Nausea, vomiting, diarrhea, constipation, headache, abdominal pain, and fatigue.
For additional information and to report adverse effects, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.
This information is for educational purposes and is not a substitute for professional medical advice. Please discuss any questions or concerns with your healthcare provider.
Compounded medications are available only while the FDA's shortage declaration is in effect. We do not have control over when this declaration is lifted, and once it is removed, pharmacies are unable to compound these medications for patients. As such, we cannot guarantee the continued availability of compounded medications from pharmacies, and please note that refunds will not be issued in such cases.
